Researchers at the Technical University of Munich in Germany have developed a sensitive and inexpensive microarray technology that can rapidly identify antibodies against the SARS-CoV-2 virus in blood or serum samples. The test can provide a result in as little as eight minutes, but the researchers believe that this can be further reduced to just… Read More: Microarray Rapidly Identifies Antibodies Against SARS-CoV-2 »
According to research1 conducted in Switzerland, SARS-CoV-2-specific antibodies are only found in the most severe cases — about 1 in 5. That suggests COVID-19 may in fact be five times more prevalent than suspected. It also means it may be five times less deadly than predicted. The study,2 “Systemic and Mucosal Antibody Secretion Specific to… Read More: Majority of People Are Already Resistant to SARS-CoV-2 »
Jonathan Latham, Ph.D., is a molecular biologist and a virologist, which is a great skillset to help us understand the origins of SARS-CoV-2. Latham reviews some really intriguing evidence in this interview. He’s also the editor of Independent Science News. By and large, the mainstream media are still protecting the narrative that SARS-CoV-2 is a… Read More: Cover-Up of SARS-CoV-2 Exposed »